To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation.
Company Details
- Employees
- 4
- Founded
- 2019
- Address
- 4 Rue Pierre Fontaine, Evry-Coucouronnes,france 91000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.innovhem.fr/
- HQ
- EVRY-COUCOURONNES, FRANCE
Innovhem Questions
Innovhem's website is https://www.innovhem.fr/
Innovhem's LinkedIn profile is https://fr.linkedin.com/company/innovhem
Innovhem has
4 employees.
View email and phone details for 4
employees at Innovhem.
Innovhem's industry is
Biotechnology Research
Innovhem's top competitors are
Biokortex,
Axelife,
Astraveus,
Lifen,
Tribun Health,
Rest Therapeutics,
Inheart,
Axomove,
Biosency,
Réseau Erythrocytes Et Drépanocytose - Red.
Innovhem's categories are Biotechnology Research
Innovhem's founding year is 2019
